Skip to content

AETERNUM HEALTH, INC.: 10-Q filed 2016-10-14

What AETERNUM HEALTH, INC. reported in its quarterly report filed 2016-10-14 (fiscal Q2 2017): 21 published measures, 68 facts as tagged in accession 0001144204-16-128126.

This filing

Form
10-Q (quarterly report)
Filed
2016-10-14
Fiscal period
fiscal Q2 2017
Accession
0001144204-16-128126 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AETERNUM HEALTH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-08-31289USD
At 2016-02-29416USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-08-312,232,171USD
At 2016-02-292,193,595USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-08-31-2,231,882USD
At 2016-02-29-2,193,179USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-08-31289USD
At 2016-02-29416USD
At 2015-08-3183USD
At 2015-02-28614USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-06-01 to 2016-08-31-15,601USD92
2016-03-01 to 2016-08-31-38,703USD184
2015-06-01 to 2015-08-31-44,891USD92
2015-03-01 to 2015-08-31-52,010USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-06-01 to 2016-08-310USD92
2016-03-01 to 2016-08-310USD184
2015-06-01 to 2015-08-310USD92
2015-03-01 to 2015-08-310USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-08-31-4,915,865USD
At 2016-02-29-4,877,162USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2016-06-01 to 2016-08-313,512,527shares92
2016-03-01 to 2016-08-313,512,527shares184
2015-06-01 to 2015-08-313,512,527shares92
2015-03-01 to 2015-08-313,512,527shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2016-06-01 to 2016-08-313,512,527shares92
2016-03-01 to 2016-08-313,512,527shares184
2015-06-01 to 2015-08-313,512,527shares92
2015-03-01 to 2015-08-313,512,527shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2016-06-01 to 2016-08-310USD/shares92
2016-03-01 to 2016-08-31-0.01USD/shares184
2015-06-01 to 2015-08-31-0.01USD/shares92
2015-03-01 to 2015-08-31-0.01USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2016-06-01 to 2016-08-310USD/shares92
2016-03-01 to 2016-08-31-0.01USD/shares184
2015-06-01 to 2015-08-31-0.01USD/shares92
2015-03-01 to 2015-08-31-0.01USD/shares184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-06-01 to 2016-08-310USD92
2016-03-01 to 2016-08-310USD184
2015-06-01 to 2015-08-319,391USD92
2015-03-01 to 2015-08-319,391USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-06-01 to 2016-08-31-15,271USD92
2016-03-01 to 2016-08-31-38,063USD184
2015-06-01 to 2015-08-31-34,619USD92
2015-03-01 to 2015-08-31-41,408USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-08-31289USD
At 2016-02-29416USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-06-01 to 2016-08-31330USD92
2016-03-01 to 2016-08-31640USD184
2015-06-01 to 2015-08-31881USD92
2015-03-01 to 2015-08-311,211USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-08-312,232,171USD
At 2016-02-292,193,595USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-08-313,552,502shares
At 2016-02-293,552,502shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-08-312,679,855USD
At 2016-02-292,679,855USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-06-01 to 2016-08-31-15,601USD92
2016-03-01 to 2016-08-31-38,703USD184
2015-06-01 to 2015-08-31-35,500USD92
2015-03-01 to 2015-08-31-42,619USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-06-01 to 2016-08-310USD92
2016-03-01 to 2016-08-310USD184
2015-06-01 to 2015-08-310USD92
2015-03-01 to 2015-08-310USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2016-06-01 to 2016-08-31-330USD92
2016-03-01 to 2016-08-31-640USD184
2015-06-01 to 2015-08-31-881USD92
2015-03-01 to 2015-08-31-1,211USD184

Inspect the source

Entity
AETERNUM HEALTH, INC. / CIK 0000764630
Captured
2026-09-19T15:02:38.824Z
SEC response SHA-256
6c9d70d4b82a4edc5f4de8082c897762179c66ba1d127e497154b6262edf21b8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000764630.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))